A narrative review of alcohol consumption as a risk factor for global burden of disease

Substance Abuse: Treatment, Prevention, and Policy

Volumn 11, Issue 1, 2016, Pages

  Rehm, Jürgen ^a,b,c   Imtiaz, Sameer ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Alcohol; Average level of consumption; Burden of disease; Cause of death; Comparative risk assessment; Global; Patterns of drinking; Relative risk

Indexed keywords

ADVERSE EFFECTS; CAUSE OF DEATH; DRINKING BEHAVIOR; GLOBAL DISEASE BURDEN; HEALTH CARE POLICY; HUMAN; MORTALITY; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TRENDS;

ALCOHOL DRINKING; CAUSE OF DEATH; GLOBAL BURDEN OF DISEASE; HEALTH POLICY; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 84992535704     PISSN: None     EISSN: 1747597X     Source Type: Journal    
DOI: 10.1186/s13011-016-0081-2     Document Type: Article

References (159)

1. Murray CJL, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. WHO Bulletin. 1994;72:496-509.
2. World Bank. World Development Report 1993 -- Investing in Health. New York, ISBN 0-19-520890-0: 1993.
3. Murray CJ, Acharya AK. Understanding DALYs. J Health Econ. 1997;16:703-30.
4. Murray CJL. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Org. 1994;72:429-45.
5. Murray CJL, Salomon J, Mathers C, Lopez A. Summary measures of population health: Concepts, ethics, measurement and applications. Geneva: World Health Organization; 2002.
6. Lopez AD. Cause of death in industrial and developing countries: estimates for 1985-1990. In: Jamison DT, Mosley WH, Measham AR, Bobadilla JL, editors. Disease Control Priorities in Developing Countries. Oxford: Oxford University Press (for the World Bank); 1993. p. 35-50.
7. Ezzati M, Lopez A, Rodgers A, Murray CJL. Comparative quantification of health risks. Global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization; 2004.
8. World Health Organization. Risk Factors. 2016. http://www.who.int/topics/risk_factors/en/. Accessed 26 Sept 2016
9. World Health Organization. Global status report on alcohol and health. Geneva: World Health Organization; 2014.
10. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-60.
11. Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2287-323.
12. Murray CJL, Lopez A. Quantifying the burden of disease and injury attributable to ten major risk factors. In: Murray CJL, Lopez AD, editors. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Boston: Harvard School of Public Health on Behalf of the World Health Organization and the World Bank; 1996. p. 295-324.
13. Anderson P, Braddick F, Conrod P, Gual A, Hellman M, Matrai S, et al. The New Governance of Addictive Substances and Behaviours. Oxford: Oxford University Press; 2016.
14. Chisholm D, Rehm J, van Ommeren M, Monteiro M. Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis. J Stud Alcohol. 2004;65:782-93.
15. Chisholm D, Doran C, Shibuya K, Rehm J. Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use. Drug Alcohol Rev. 2006;25:553-65.
16. Rehm J, Room R, Monteiro M, Gmel G, Graham K, Rehn N, et al. Alcohol Use. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization; 2004. p. 959-1109.
17. Rehm J, Borges G, Gmel G, Graham K, Grant B, Parry C, et al. The comparative risk assessment for alcohol as part of the Global Burden of Disease 2010 study: What changed from the last study? Int J Alcohol Drug Res. 2013;2:1-5.
18. Institute for Health Metrics and Evaluation. GBD Compare. 2015. http://vizhub.healthdata.org/gbd-compare. Accessed 19 July 2016
19. Shield KD, Rylett M, Rehm J. Public health gains and missed opportunities. Trends in alcohol consumption and attributable mortality in the WHO European Region, 1990-2014: A Report to the WHO European Region. Toronto, Canada: Centre for Addiction and Mental Health; ISBN - 978-1-77114-367-7. 2016
20. Shield KD, Rylett M, Rehm J. Public health successes and missed opportunities. Trends in alcohol consumption and attributable mortality in the WHO European Region, 1990-2014. Copenhagen: WHO European Region; 2016.
21. Shield KD, Popova S, Rehm J. The burden of disease and injury caused by alcohol. Reference Module in Biomedical Sciences. Elsevier online via science direct. doi: 10.1016/B978-0-12-801238-3.03188-3. Reference Module in Biomedical Sciences, Elsevier online via science direct. 2015.
22. World Health Organization. Civil registration: why counting births and deaths is important. Geneva, Switzerland: World Health Organization; 2014. http://www.who.int/mediacentre/factsheets/fs324/en/. Accessed 19 July 2016
23. Murray CJ, Lozano R, Flaxman AD, Serina P, Phillips D, Stewart A, et al. Using verbal autopsy to measure causes of death: the comparative performance of existing methods. BMC Med. 2014;12:5.
24. Rehm J, Mathers C. Global comparative risk assessment - what level of detail can be achieved? Lancet. 2009;374:477.
25. Goerdt A, Koplan J, Robine J, Thuriaux M, van Ginneken J. Non-fatal health outcomes: Concepts, instruments and indicators. In: Murray C, Lopez A, editors. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Boston: Harvard School of Public Health on behalf of the World Health Organization and the World Bank; 1996. p. 99-117.
26. Flaxman AD, Vos T, Murray CJL. An Integrative Metaregression Framework for Descriptive Epidemiology. Washington: University of Washington Press; 2015.
27. Rehm J, Frick U. Valuation of health states in the U.S. study to establish disability weights: lessons from the literature. Int J Methods Psychiatr Res. 2010;19:18-33.
28. Institute for Health Metrics and Evaluation. Global Burden of Disease (GBD). 2016. http://www.healthdata.org/gbd. Accessed 19 July 2016.
29. World Health Organization. Global Health Estimates (GHE). 2016. http://www.who.int/healthinfo/global_burden_disease/en/. Accessed 19 July 2016.
30. Kovacs SD, Mullholland K, Bosch J, Campbell H, Forouzanfar MH, Khalil I, et al. Deconstructing the differences: a comparison of GBD 2010 and CHERG's approach to estimating the mortality burden of diarrhea, pneumonia, and their etiologies. BMC Infectious Disease. 2015;16:16.
31. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012;380:2129-43.
32. Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, et al. Disability weights for the global burden of disease 2013 study. Lancet Global Health. 2015;3:e712-23.
33. Burstein R, Fleming T, Haagsma J, Salomon JA, Vos T, Murray CJ. Estimating distributions of health state severity for the global burden of disease study. Popul Health Metr. 2015;18:31.
34. Rehm J. How should prevalence of alcohol use disorders be assessed globally? Int J Methods Psychiatr Res. 2016;25:79-85.
35. Guzzo-Merello G, Cobo-Marcos M, Gallego-Delgado M, Garcia-Pavia P. Alcoholic cardiomyopathy. World J Cardiol. 2014;6:771-81.
36. Majumder S, Chari ST. Chronic pancreatitis. Lancet. 2016;387:1957-66.
37. Irving HM, Samokhvalov A, Rehm J. Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP. 2009;10:387-92.
38. Samokhvalov AV, Rehm J, Roerecke M. Alcohol consumption as a risk factor for acute and chronic pancreatitis: a systematic review and a series of meta-analyses. EBioMedicine. 2015;2:1996-2002.
39. Rehm J, Dawson D, Frick U, Gmel G, Roerecke M, Shield KD, et al. Burden of disease associated with alcohol use disorders in the United States. Alcohol Clin Exp Res. 2014;38:1068-77.
40. Samokhvalov AV, Popova S, Room R, Ramonas M, Rehm J. Disability associated with alcohol abuse and dependence. Alcohol Clin Exp Res. 2010;34:1871-8.
41. Popova S, Lange S, Shield KD, Mihic A, Chudley AE, Mukherjee RAS, et al. Co-morbidity of fetal alcohol spectrum disorder: a systematic literature review and metaanalysis. Lancet. 2016;387:978-87.
42. Rehm J, Shield K. Alcohol consumption. In: Steward BW, Wild CP, editors. World Cancer Report. Lyon: International Agency for Research on Cancer; 2014. p. 97-107.
43. International Agency for Research on Cancer. Alcohol Drinking. Lyon: International Agency for Research on Cancer; 1988.
44. International Agency for Research on Cancer: IARC Monographs on the evaluation of carcinogenic risks to humans: Alcohol consumption and ethyl carbamate. In., vol. 96. Lyon, France: International Agency for Research on Cancer; 2010.
45. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans 100E Personal Habits and Indoor Combustions. Lyon: International Agency for Research on Cancer; 2012.
46. Leoncini E, Carioli G, La Vecchia C, Boccia S, Rindi G. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis. Ann Oncol. 2016;27:68-81.
47. Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2015;112:580-93.
48. Rush B. An inquiry into the effects of ardent spirits upon the human body and mind: With an account of the means of preventing, and of the remedies for curing them. 8th edition. Reprint. Richardson: Exeter, N.H; 1785.
49. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008.
50. Parry C, Rehm J, Poznyak V, Room R. Alcohol and infectious diseases: an overlooked causal linkage? Addiction. 2009;104:331-2.
51. Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry CD, Lönnroth K, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. 2009;9:450.
52. Samokhvalov AV, Irving HM, Rehm J. Alcohol consumption as a risk factor for pneumonia: systematic review and meta-analysis. Epidemiol Infect. 2010;138:1789-95.
53. Baliunas D, Rehm J, Irving H, Shuper P. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health. 2010;55:159-66.
54. Parry CDH, Rehm J, Morojele NK. Is there a causal relationship between alcohol and HIV? African J Drug Alcohol Studies. 2010;9:81-92.
55. Fisher JC, Bang H, Kapiga SH. The association between HIV infection and alcohol use: a systematic review and meta-analysis of African studies. Sex Transm Dis. 2007;34:856-63.
56. Gmel G, Shield K, Rehm J. Developing a methodology to derive alcohol-attributable fractions for HIV/AIDS mortality based on alcohol's impact on adherence to antiretroviral medication. Popul Health Metr. 2011;9:5.
57. Rehm J, Shield KD, Joharchi N, Shuper PA. Alcohol consumption and the intention to engage in unprotected sex: systematic review and meta-analysis of experimental studies. Addiction. 2012;107:51-9.
58. Scott-Sheldon LA, Carey KB, Cunningham K, Johnson BT, Carey MP. Alcohol use predicts sexual decision-making: a systematic review and meta-analysis of the experimental literature. AIDS Behav. 2015;Suppl 1:S19-39.
59. Ferreira-Borges C, Rehm J, Dias S, Babor T, Parry CD. The impact of alcohol consumption on African people in 2012: an analysis of burden of disease. Trop Med Int Health. 2016;21:52-60.
60. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997;54:313-21.
61. Regier D, Farmer M, Rae D, Locke B, Keith S, Judd L, et al. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiological Catchment Area (ECA) Study. JAMA. 1990;264:2511-8.
62. Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol. 1988;49:219-24.
63. Rehm J, Anderson P, Gual A, Kraus L, Marmet S, Room R, et al. The tangible common denominator of substance use disorders: a reply to commentaries to Rehm et al. (2013). Alcohol Alcohol. 2014;49:118-22.
64. Rehm J, Marmet S, Anderson P, Gual A, Kraus L, Nutt DJ, et al. Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol. 2013;48:633-40.
65. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th edition). Philadelphia: American Psychiatric Association; 2013.
66. World Health Organization. ICD-10 Classification of mental and behavioural disorders: with glossary and diagnostic criteria for research. New York: Churchill Livingstone; 1994.
67. Boden JM, Fergusson DM. Alcohol and depression. Addiction. 2011;106:906-14.
68. Foulds JA, Adamson SJ, Boden JM, Williman JA, Mulder RT. Depression in patients with alcohol use disorders: Systematic review and meta-analysis of outcomes for independent and substance-induced disorders. J Affect Disord. 2015;1:47-59.
69. Samokhvalov AV, Irving H, Mohapatra S, Rehm J. Alcohol consumption, unprovoked seizures and epilepsy: a systematic review and meta-analysis. Epilepsia. 2010;51:1177-84.
70. Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, et al. Alcohol as a risk factor for liver cirrhosis - a systematic review and meta-analysis. Drug Alcohol Rev. 2010;29:437-45.
71. Baliunas D, Taylor B, Irving H, Roerecke M, Patra J, Mohapatra S, et al. Alcohol as a risk factor for type 2 diabetes - A systematic review and meta-analysis. Diabetes Care. 2009;32:2123-32.
72. Roerecke M, Rehm J. Alcohol intake revisited: risks and benefits. Curr Atheroscler Rep. 2012;14:556-62.
73. Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, et al. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 2009;104:1981-90.
74. Roerecke M, Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med. 2014;12:182.
75. Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S, et al. Alcohol consumption and the risk of morbidity and mortality from different stroke types - a systematic review and meta-analysis. BMC Public Health. 2010;10:258.
76. Samokhvalov AV, Irving HM, Rehm J. Alcohol as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiov Prev R. 2010;17:706-12.
77. Cherpitel C, Ye Y, Bond J, Borges G, Autonoma M, Monteiro M, et al. Alcohol attributable fraction for injury morbidity from the dose-response relationship of acute alcohol consumption: emergency department data from 18 countries. Addiction. 2015;110:1724-32.
78. Rehm J. Commentary on Cherpitel et al. (2015): improving global estimates of alcohol-attributable injury. Addiction. 2015;110:1733-4.
79. Gell L, Ally A, Buykx P, Hope A, Meier P. Alcohol's harm to others: An Insitute of Alcohol Studies report. United Kingdom: Institute of Alcohol Studies; 2015.
80. Laslett AM, Catalano P, Chikritzhs T, Dale C, Doran C, Ferris J, et al. The range and magnitude of alcohol's harm to others. Fitzroy: Turning Point Alcohol & Drug Centre; 2010.
81. Shield KD, Rylett MJ, Gmel G, Rehm J. Trends in alcohol consumption and alcohol-attributable mortality in the EU in 2010. In: World Health Organization Regional Office for Europe, editor. Status report on alcohol and health in 35 European countries. Copenhagen: WHO Regional Office for Europe; 2013.
82. Patra J, Bakker R, Irving H, Jaddoe VWV, Malini S, Rehm J. Dose-response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)-a systematic review and meta-analyses. Int J Gynaecol Obstet. 2011;118:1411-21.
83. Shield KD, Parry C, Rehm J. Chronic diseases and conditions related to alcohol use. Alcohol Res. 2013;35:155-71.
84. Shield K, Rehm J. Russia-specific relative risks and their effects on the estimated alcohol-attributable burden of disease. BMC Public Health. 2015;15:482.
85. Shield KD, Soerjomataram I, Rehm J. Alcohol use and breast cancer: a critical review. Alcohol Clin Exp Res. 2016;40:1166-81.
86. Rehm J. Light or moderate drinking is linked to alcohol related cancers, including breast cancer. BMJ. 2015;351:h4400.
87. Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004;38:613-9.
88. Rehm J, Baliunas D, Borges GL, Graham K, Irving HM, Kehoe T, et al. The relation between different dimensions of alcohol consumption and burden of disease - An overview. Addiction. 2010;105:817-43.
89. Rehm J, Shield KD, Roerecke M, Gmel G. Modelling the impact of alcohol consumption on cardiovascular disease mortality for comparative risk assessments: an overview. BMC Public Health. 2016;16:363.
90. Roerecke M, Rehm J. Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am J Epidemiol. 2010;171:633-44.
91. Mostofsky E, van der Bom JG, Mukamal KJ, Maclure M, Tofler M, Tofler GH, et al. Risk of myocardial infarction immediately after alcohol consumption. Epidemiology. 2015;26:143-50.
92. Marmot MG, Shipley MJ, Rose G, Thomas B. Alcohol and mortality: a U-shaped curve. Lancet. 1981;317:580-3.
93. European Association for the Study of the Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol. 2012;57:j399-420.
94. Lachenmeier DW, Kanteres F, Rehm J. Epidemiology-based risk assessment using the benchmark dose/margin of exposure approach: the example of ethanol and liver cirrhosis. Int J Epidemiol. 2011;40:210-8.
95. Rehm J, Roerecke M. Patterns of drinking and liver cirrhosis - what do we know and where do we go? J Hepatol. 2015;62:1061-7.
96. Sindelar H, Barnett N, Spirito A. Adolescent alcohol use and injury. A summary and critical review of the literature. Minerva Pediatr. 2004;56:291-309.
97. Rehm J, Gmel G, Sempos C, Trevisan M. Alcohol-related mortality and morbidity. Alcohol Res Health. 2003;27:39-51.
98. Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A, et al. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths. Lancet. 2009;373:2201-14.
99. Zaridze D, Lewington S, Boroda A, Scélo G, Karpov R, Lazarev A, et al. Alcohol and mortality in Russia: prospective observational study of 151,000 adults. Lancet. 2014;383:1465-73.
100. Rehm J. What can we learn from Russia about alcohol epidemiology and alcohol policy? Lancet. 2014;383:1440-2.
101. Room R, Jernigan D, Carlini BH, Gmel G, Gureje O, Mäkelä K, et al. El alcohol y los países en desarrollo. Una perspectiva de salud pública. Mexico: Organización Panamericana de la Salud & Fondo de Cultura Económica; 2013.
102. Rehm J, Monteiro M, Room R, Gmel G, Jernigan D, Frick U, et al. Steps towards constructing a global comparative risk analysis for alcohol consumption: Determining indicators and empirical weights for patterns of drinking, deciding about theoretical minimum, and dealing with different consequences. Eur Addict Res. 2001;7:138-47.
103. Brooks PJ, Enoch MA, Goldman D, Li TK, Yokoyama A. The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med. 2009;6:258-63.
104. Roerecke M, Shield KD, Higuchi S, Yoshimura A, Larsen E, Rehm MX, et al. Estimates of alcohol-related oesophageal cancer burden in Japan: systematic review and meta-analyses. Bull World Health Org. 2015;93:329-338c.
105. Murray CJL, Ezzati M, Lopez AD, Rodgers A, Vander HS. Comparative quantification of health risks: conceptual framework and methodological issues. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative Quantification of Health Risks: Global and regional Burden of Disease attributable to selected major risk factors. Geneva: World Health Organization; 2004. p. 1-38.
106. Vander Hoorn S, Ezzati M, Rodgers A, Lopez AD, Murray CJL. Estimating attributable burden of disease from exposure and hazard data. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva: World Health Organization; 2004. p. 2129-40.
107. Walter SD. The estimation and interpretation of attributable risk in health research. Biometrics. 1976;32:829-49.
108. Walter SD. Prevention of multifactorial disease. Am J Epidemiol. 1980;112:409-16.
109. Murray CJL, Lopez A. On the comparable quantification of health risks: lessons from the global burden of disease study. Epidemiology. 1999;10:594-605.
110. Rehm J, Kehoe T, Gmel G, Stinson F, Grant B, Gmel G. Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the example of the US. Popul Health Metr. 2010;8:3.
111. Rehm J, Klotsche J, Patra J. Comparative quantification of alcohol exposure as risk factor for global burden of disease. Int J Methods Psychiatr Res. 2007;16:66-76.
112. Kehoe T, Gmel Jr G, Shield K, Gmel Sr G, Rehm J. Determining the best population-level alcohol consumption model and its impact on estimates of alcohol-attributable harms. Popul Health Metr. 2012;10:6.
113. Gmel G, Rehm J. Measuring alcohol consumption. Contemp Drug Probl. 2004;31:467-540.
114. Poznyak V, Fleischmann A, Rekve D, Rylett M, Rehm J, Gmel G. The World Health Organization's Global monitoring system on alcohol and health. Alcohol Res. 2013;35:244-9.
115. Midanik LT. The validity of self-reported alcohol consumption and alcohol problems: a literature review. Br J Addict. 1982;77:357-82.
116. Midanik L. Validity of self-reported alcohol use: a literature review and assessment. Br J Addict. 1988;83:1019-29.
117. Shield K, Kehoe T, Taylor B, Patra J, Rehm J. Alcohol-attributable burden of disease and injury in Canada, 2004. Int J Public Health. 2012;57:391-401.
118. Ramstedt M. How much alcohol do you buy? A comparison of self-reported alcohol purchases with actual sales. Addiction. 2010;105:649-54.
119. Ministry of Health. Alcohol Use in New Zealand: Key results of the 2007/08 New Zealand Alcohol and Drug Use Survey. Wellington: Ministry of Health; 2009.
120. King AC. Enhancing the self-report of alcohol consumption in the community: two questionnaire formats. Am J Public Health. 1994;84:294-6.
121. Willett W. Nutritional epidemiology. Oxford: Oxford University Press; 2012.
122. Giovannucci E, Colditz G, Stampfer MJ, Rimm EB, Litin L, Sampson L, et al. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol. 1991;133:810-7.
123. Shield K, Rehm J. Difficulties with telephone-based surveys on alcohol in high-income countries: the Canadian example. Int J Methods Psychiatr Res. 2012;21:17-28.
124. Rey G, Boniol M, Jougla E. Estimating the number of alcohol-attributable deaths: methodological issues and illustration with French data for 2006. Addiction. 2010;105:1018-29.
125. Rehm J. Commentary on Rey et al. (2010): How to improve estimates on alcohol-attributable burden? Addiction. 2010;105:1030-1.
126. Holmes J, Meier PS, Booth A, Guo Y, Brennan A. The temporal relationship between per capita alcohol consumption and harm: a systematic review of time lag specifications in aggregate time series analyses. Drug Alcohol Depend. 2012;123:7-14.
127. Rehm J. Alcohol consumption and mortality. What do we know and where should we go? Addiction. 2000;95:989-95.
128. Kontis V, Mathers CD, Rehm J, Stevens GA, Shield KD, Bonita R, et al. Contribution of six risk factors to achieving the "25×25" NCD mortality reduction target. Lancet. 2014;384:427-37.
129. Kontis V, Mathers CD, Bonita R, Stevens GA, Rehm J, Shield KD, et al. Regional contributions of six preventable risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study. Lancet Global Health. 2015;3:e746-57.
130. Gmel G, Kuntsche E, Rehm J. Risky single occasion drinking: bingeing is not bingeing. Addiction. 2011;106:1037-45.
131. Gmel G, Kuntsche E, Rehm J. Risky single occasion drinking research: the four stages of enlightenment. Addiction. 2011;106:1050-1.
132. Praud D, Rota M, Rehm J, Shield K, Zatonski W, Hashibe M, et al. Cancer incidence and mortality attributable to alcohol consumption. Int J Cancer. 2016;138:1380-7.
133. Gmel G, Rehm J. Harmful alcohol use. Alcohol Res Health. 2003;27:52-62.
134. Roberts H, Meddings D. Violence and unintentional injury: equity and social determinants. In: Blas E, Kurup AS, editors. Equity, social determinants and public health programmes. Geneva: World Health Organization; 2010. p. 243-59.
135. Room R, Ferris J, Laslett AM, Livingston M, Mugavin J, Wilkinson C. The drinker's effect on the social environment: a conceptual framework for studying alcohol's harmto others. Int J Environ Res Public Health. 2010;7:1855-71.
136. World Health Organization. Global status report on road safety 2015. Geneva: World Health Organization; 2015.
137. Lange S, Probst C, Heer N, Roerecke M, Rehm J, Monteiro MG et al. Actual and predicted prevalence of alcohol consumption during pregnancy in Latin America and the Caribbean: systematic literature review and meta-analysis. Revista Panamericana de Salud Pública/Pan American Journal of Public Health. 2016; epub ahead of print
138. Popova S, Lange S, Probst C, Gmel G, Rehm J. Estimation of national, regional and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Toronto: Centre for Addiction and Mental Health; 2016.
139. Kamerstuk - Eerste Kamer der Staten-General. 33 799 Wijziging van het Wetboek van Strafvordering in verband met de introductie van de bevoegdheid tot het bevelen van een middelenonderzoek bij geweldplegers en enige daarmee samenhangende wijzigingen van de Wegenverkeerswet 1994 [33 799 Amendment of the Code of Criminal Procedure in connection with the introduction of the power to recommend an agent study of violent offenders and any related amendments to the Road Traffic Act 1994]. Netherlands: Verheid; 2016.
140. Babor T, Caetano R, Casswell S, Edwards G, Giesbrecht N, Graham K, et al. Alcohol: No ordinary commodity. Research and public policy. 2nd edition. Oxford and London: Oxford University Press; 2010.
141. Anderson P, Chisholm D, Fuhr D. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet. 2009;373:2234-46.
142. World Health Organization. Global Action Plan for the Prevention and Control of NCDs 2013-2020. Geneva: World Health Organization; 2013.
143. World Economic Forum & World Health Organization. From burden to "best buys": Reducing the economic impact of non-communicable diseases in low- and middle-income countries. Davos: World Economic Forum; 2011.
144. Rabinovich L, Brutscher PB, de Vries H, Tiessen J, Clift J, Reding A. The affordability of alcoholic beverages in the European Union: Understanding the link between alcohol affordability, consumption and harms. 2009. RAND Europe.
145. Rehm J, Lachenmeier DW, Jané Llopis E, Imtiaz S, Anderson P. Evidence of reducing ethanol content in beverages to reduce harmful use of alcohol. Lancet Gastroenterol Hepatol. 2016;1:78-83.
146. Rehm J, Shield KD, Rehm MX, Gmel G, Frick U. Modelling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol. 2013;23:89-97.
147. Purshouse CR, Meier PS, Brennan A, Taylor KB, Rafia R. Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model. Lancet. 2010;375:1355-64.
148. Holmes J, Meng Y, Meier PS, Brennan A, Angus C, Campbell-Burton A, et al. Effects of minimum unit pricing for alcohol on different income and socioeconomic groups: a modelling study. Lancet. 2014;383:1655-64.
149. Health and Safety Executive. Don't mix it: A guide for employers on alcohol at work. United Kingdom: Crown; 1996.
150. Rehm J, Zatonski W, Taylor B, Anderson P. Epidemiology and alcohol policy in Europe. Addiction. 2011;106:11-9.
151. Killoran A, Canning U, Doyle N, Sheppard L. Centre for Public Health Excellence NICE 2010 Review of effectiveness of laws limiting blood alcohol concentration levels to reduce alcohol-related road injuries anddeaths. http://www.ias.org.uk/uploads/pdf/bloodalcoholcontenteffectivenessreview.pdf. Accessed 22 Oct 2016.
152. Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59:160-8.
153. Zatonski W, Sulkowska U, Manczuk M, Rehm J, Lowenfels AB, La Vecchia C. Liver cirrhosis mortality in Europe, with special attention to central and eastern Europe. Eur Addict Res. 2010;16:193-201.
154. Rehm J, Taylor B, Patra J, Gmel G. Avoidable burden of disease: conceptual and methodological issues in substance abuse epidemiology. Int J Methods Psychiatr Res. 2006;15:181-91.
155. Murray CJL, Lopez A. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet. 1997;349:1436-42.
156. Ezzati M, Lopez AD, Rodgers AD, Vander Horn S, Murray CJL, Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347-60.
157. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol use disorders. Lancet. 2009;373:2223-33.
158. Lönnroth K, Williams B, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis - a systematic review. BMC Public Health. 2008;8:289.
159. Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction. 2012;107:1246-60.